HEADER TRANSFERASE 17-FEB-15 5AIS TITLE COMPLEX OF HUMAN HEMATOPOIETIC PROSTAGANDIN D2 SYNTHASE (HH-PGDS) IN TITLE 2 COMPLEX WITH AN ACTIVE SITE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: H-PGDS, GST CLASS-SIGMA, GLUTATHIONE S-TRANSFERASE, GLUTATH COMPND 5 IONE-DEPENDENT PGD SYNTHASE, GLUTATHIONE-REQUIRING PROSTAGLANDIN D COMPND 6 SYNTHASE, PROSTAGLANDIN-H2 D-ISOMERASE; COMPND 7 EC: 5.3.99.2, 2.5.1.18; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, PROSTAGLANDIN D2 SYNTHASE, PGDS INHIBITORS, INDOLE, KEYWDS 2 FOCUSED SCREENING, HIT VALIDATION EXPDTA X-RAY DIFFRACTION AUTHOR F.EDFELDT,J.EVENAS,M.LEPISTO,A.WARD,J.PETERSEN,L.WISSLER,M.ROHMAN, AUTHOR 2 U.SIVARS,K.SVENSSON,M.PERRY,I.FEIERBERG,X.ZHOU,T.HANSSON,F.NARJES REVDAT 3 08-MAY-24 5AIS 1 REMARK LINK REVDAT 2 10-JUN-15 5AIS 1 JRNL REVDAT 1 03-JUN-15 5AIS 0 JRNL AUTH F.EDFELDT,J.EVEN,M.LEPISTO,A.WARD,J.PETERSEN,L.WISSLER, JRNL AUTH 2 M.ROHMAN,U.SIVARS,K.SVENSSON,M.PERRY,I.FEIERBERG,X.H.ZHOU, JRNL AUTH 3 T.HANSSON,F.NARJES JRNL TITL IDENTIFICATION OF INDOLE INHIBITORS OF HUMAN HEMATOPOIETIC JRNL TITL 2 PROSTAGLANDIN D2 SYNTHASE (HH-PGDS). JRNL REF BIOORG.MED.CHEM.LETT. V. 25 2496 2015 JRNL REFN ISSN 0960-894X JRNL PMID 25978964 JRNL DOI 10.1016/J.BMCL.2015.04.065 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0027 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 64497 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3439 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4514 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.52 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 237 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6552 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 178 REMARK 3 SOLVENT ATOMS : 288 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.194 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.123 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.102 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6962 ; 0.004 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6483 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9468 ; 0.814 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14910 ; 0.670 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 800 ; 4.090 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 337 ;31.973 ;24.273 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1177 ;12.462 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;10.747 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1018 ; 0.044 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7918 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1624 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 5AIS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1290063074. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.939 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69399 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 49.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 1.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y,Z REMARK 290 7555 -Y+1/2,X,Z+3/4 REMARK 290 8555 Y,-X+1/2,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 62.40100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 62.40100 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.44200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 62.40100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.72100 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 62.40100 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 80.16300 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 62.40100 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.40100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.44200 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 62.40100 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 80.16300 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 62.40100 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 26.72100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 1 REMARK 465 HIS B 1 REMARK 465 HIS C 1 REMARK 465 HIS D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 107.36 69.14 REMARK 500 GLN B 63 108.48 69.43 REMARK 500 ARG C 12 -70.26 -67.68 REMARK 500 GLN C 63 110.48 70.51 REMARK 500 GLN D 63 108.35 70.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2044 O REMARK 620 2 HOH A2045 O 81.6 REMARK 620 3 HOH A2049 O 87.0 86.4 REMARK 620 4 HOH B2048 O 100.2 89.2 171.0 REMARK 620 5 HOH B2051 O 169.0 100.3 82.3 90.7 REMARK 620 6 HOH B2052 O 87.9 168.0 99.0 86.9 91.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG D1201 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH C2043 O REMARK 620 2 HOH C2045 O 85.2 REMARK 620 3 HOH C2049 O 87.8 85.5 REMARK 620 4 HOH D2029 O 87.3 77.7 162.8 REMARK 620 5 HOH D2030 O 88.5 161.8 111.4 84.9 REMARK 620 6 HOH D2031 O 169.8 91.4 82.3 101.4 97.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CWC C 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CWC D 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CWC A 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CWC B 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG D 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH D 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH C 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AIV RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN HEMATOPOIETIC PROSTAGANDIN D2 SYNTHASE ( HH-PGDS) REMARK 900 IN COMPLEX WITH AN ACTIVE SITE INHIBITOR. DBREF 5AIS A 2 199 UNP O60760 HPGDS_HUMAN 2 199 DBREF 5AIS B 2 199 UNP O60760 HPGDS_HUMAN 2 199 DBREF 5AIS C 2 199 UNP O60760 HPGDS_HUMAN 2 199 DBREF 5AIS D 2 199 UNP O60760 HPGDS_HUMAN 2 199 SEQADV 5AIS HIS A 1 UNP O60760 EXPRESSION TAG SEQADV 5AIS HIS B 1 UNP O60760 EXPRESSION TAG SEQADV 5AIS HIS C 1 UNP O60760 EXPRESSION TAG SEQADV 5AIS HIS D 1 UNP O60760 EXPRESSION TAG SEQRES 1 A 199 HIS PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG GLY SEQRES 2 A 199 ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU ASP SEQRES 3 A 199 ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP TRP SEQRES 4 A 199 PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE PRO SEQRES 5 A 199 ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER LEU SEQRES 6 A 199 ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU ALA SEQRES 7 A 199 GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA ILE SEQRES 8 A 199 VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO TRP SEQRES 9 A 199 ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE ASN SEQRES 10 A 199 GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN ASP SEQRES 11 A 199 LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE GLY SEQRES 12 A 199 ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE CYS SEQRES 13 A 199 SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU ASP SEQRES 14 A 199 ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL GLN SEQRES 15 A 199 ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG PRO SEQRES 16 A 199 GLN THR LYS LEU SEQRES 1 B 199 HIS PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG GLY SEQRES 2 B 199 ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU ASP SEQRES 3 B 199 ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP TRP SEQRES 4 B 199 PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE PRO SEQRES 5 B 199 ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER LEU SEQRES 6 B 199 ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU ALA SEQRES 7 B 199 GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA ILE SEQRES 8 B 199 VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO TRP SEQRES 9 B 199 ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE ASN SEQRES 10 B 199 GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN ASP SEQRES 11 B 199 LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE GLY SEQRES 12 B 199 ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE CYS SEQRES 13 B 199 SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU ASP SEQRES 14 B 199 ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL GLN SEQRES 15 B 199 ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG PRO SEQRES 16 B 199 GLN THR LYS LEU SEQRES 1 C 199 HIS PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG GLY SEQRES 2 C 199 ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU ASP SEQRES 3 C 199 ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP TRP SEQRES 4 C 199 PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE PRO SEQRES 5 C 199 ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER LEU SEQRES 6 C 199 ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU ALA SEQRES 7 C 199 GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA ILE SEQRES 8 C 199 VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO TRP SEQRES 9 C 199 ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE ASN SEQRES 10 C 199 GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN ASP SEQRES 11 C 199 LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE GLY SEQRES 12 C 199 ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE CYS SEQRES 13 C 199 SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU ASP SEQRES 14 C 199 ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL GLN SEQRES 15 C 199 ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG PRO SEQRES 16 C 199 GLN THR LYS LEU SEQRES 1 D 199 HIS PRO ASN TYR LYS LEU THR TYR PHE ASN MET ARG GLY SEQRES 2 D 199 ARG ALA GLU ILE ILE ARG TYR ILE PHE ALA TYR LEU ASP SEQRES 3 D 199 ILE GLN TYR GLU ASP HIS ARG ILE GLU GLN ALA ASP TRP SEQRES 4 D 199 PRO GLU ILE LYS SER THR LEU PRO PHE GLY LYS ILE PRO SEQRES 5 D 199 ILE LEU GLU VAL ASP GLY LEU THR LEU HIS GLN SER LEU SEQRES 6 D 199 ALA ILE ALA ARG TYR LEU THR LYS ASN THR ASP LEU ALA SEQRES 7 D 199 GLY ASN THR GLU MET GLU GLN CYS HIS VAL ASP ALA ILE SEQRES 8 D 199 VAL ASP THR LEU ASP ASP PHE MET SER CYS PHE PRO TRP SEQRES 9 D 199 ALA GLU LYS LYS GLN ASP VAL LYS GLU GLN MET PHE ASN SEQRES 10 D 199 GLU LEU LEU THR TYR ASN ALA PRO HIS LEU MET GLN ASP SEQRES 11 D 199 LEU ASP THR TYR LEU GLY GLY ARG GLU TRP LEU ILE GLY SEQRES 12 D 199 ASN SER VAL THR TRP ALA ASP PHE TYR TRP GLU ILE CYS SEQRES 13 D 199 SER THR THR LEU LEU VAL PHE LYS PRO ASP LEU LEU ASP SEQRES 14 D 199 ASN HIS PRO ARG LEU VAL THR LEU ARG LYS LYS VAL GLN SEQRES 15 D 199 ALA ILE PRO ALA VAL ALA ASN TRP ILE LYS ARG ARG PRO SEQRES 16 D 199 GLN THR LYS LEU HET CWC A1200 24 HET GSH A1201 20 HET CWC B1200 24 HET MG B1201 1 HET GSH B1202 20 HET CWC C1200 24 HET GSH C1201 20 HET CWC D1200 24 HET MG D1201 1 HET GSH D1202 20 HETNAM CWC 4-(DIMETHYLAMINO)-N-[5-(1H-INDOL-4-YL)PYRIDIN-3- HETNAM 2 CWC YL]BUTANAMIDE HETNAM GSH GLUTATHIONE HETNAM MG MAGNESIUM ION FORMUL 5 CWC 4(C19 H22 N4 O) FORMUL 6 GSH 4(C10 H17 N3 O6 S) FORMUL 8 MG 2(MG 2+) FORMUL 15 HOH *288(H2 O) HELIX 1 1 ARG A 12 ARG A 14 5 3 HELIX 2 2 ALA A 15 LEU A 25 1 11 HELIX 3 3 ASP A 38 LEU A 46 1 9 HELIX 4 4 GLN A 63 THR A 72 1 10 HELIX 5 5 THR A 75 GLY A 79 5 5 HELIX 6 6 THR A 81 SER A 100 1 20 HELIX 7 7 LYS A 108 TYR A 122 1 15 HELIX 8 8 TYR A 122 GLY A 136 1 15 HELIX 9 9 THR A 147 LYS A 164 1 18 HELIX 10 10 HIS A 171 ILE A 184 1 14 HELIX 11 11 ILE A 184 ARG A 194 1 11 HELIX 12 12 ARG B 12 ARG B 14 5 3 HELIX 13 13 ALA B 15 LEU B 25 1 11 HELIX 14 14 GLU B 35 ALA B 37 5 3 HELIX 15 15 ASP B 38 SER B 44 1 7 HELIX 16 16 GLN B 63 LYS B 73 1 11 HELIX 17 17 THR B 81 SER B 100 1 20 HELIX 18 18 LYS B 108 ASN B 123 1 16 HELIX 19 19 ASN B 123 GLY B 136 1 14 HELIX 20 20 THR B 147 LYS B 164 1 18 HELIX 21 21 HIS B 171 ILE B 184 1 14 HELIX 22 22 ILE B 184 ARG B 194 1 11 HELIX 23 23 ALA C 15 LEU C 25 1 11 HELIX 24 24 ASP C 38 LEU C 46 1 9 HELIX 25 25 GLN C 63 LYS C 73 1 11 HELIX 26 26 THR C 81 SER C 100 1 20 HELIX 27 27 LYS C 108 ASN C 123 1 16 HELIX 28 28 ASN C 123 GLY C 136 1 14 HELIX 29 29 THR C 147 LYS C 164 1 18 HELIX 30 30 HIS C 171 ALA C 183 1 13 HELIX 31 31 ILE C 184 ARG C 194 1 11 HELIX 32 32 ARG D 12 ARG D 14 5 3 HELIX 33 33 ALA D 15 ASP D 26 1 12 HELIX 34 34 ASP D 38 LEU D 46 1 9 HELIX 35 35 GLN D 63 LYS D 73 1 11 HELIX 36 36 THR D 81 CYS D 101 1 21 HELIX 37 37 LYS D 108 ASN D 123 1 16 HELIX 38 38 ASN D 123 GLY D 136 1 14 HELIX 39 39 THR D 147 LYS D 164 1 18 HELIX 40 40 HIS D 171 ALA D 183 1 13 HELIX 41 41 ILE D 184 ARG D 194 1 11 SHEET 1 AA 4 GLU A 30 ILE A 34 0 SHEET 2 AA 4 TYR A 4 PHE A 9 1 O TYR A 4 N GLU A 30 SHEET 3 AA 4 ILE A 53 VAL A 56 -1 O ILE A 53 N THR A 7 SHEET 4 AA 4 LEU A 59 HIS A 62 -1 O LEU A 59 N VAL A 56 SHEET 1 BA 4 GLU B 30 ILE B 34 0 SHEET 2 BA 4 TYR B 4 PHE B 9 1 O TYR B 4 N GLU B 30 SHEET 3 BA 4 ILE B 53 VAL B 56 -1 O ILE B 53 N THR B 7 SHEET 4 BA 4 THR B 60 HIS B 62 -1 O LEU B 61 N LEU B 54 SHEET 1 CA 4 TYR C 29 ILE C 34 0 SHEET 2 CA 4 TYR C 4 PHE C 9 1 O TYR C 4 N GLU C 30 SHEET 3 CA 4 ILE C 53 VAL C 56 -1 O ILE C 53 N THR C 7 SHEET 4 CA 4 LEU C 59 HIS C 62 -1 O LEU C 59 N VAL C 56 SHEET 1 DA 4 GLU D 30 ILE D 34 0 SHEET 2 DA 4 TYR D 4 PHE D 9 1 O TYR D 4 N GLU D 30 SHEET 3 DA 4 ILE D 53 VAL D 56 -1 O ILE D 53 N THR D 7 SHEET 4 DA 4 LEU D 59 HIS D 62 -1 O LEU D 59 N VAL D 56 LINK O HOH A2044 MG MG B1201 1555 1555 2.15 LINK O HOH A2045 MG MG B1201 1555 1555 2.17 LINK O HOH A2049 MG MG B1201 1555 1555 2.17 LINK MG MG B1201 O HOH B2048 1555 1555 2.15 LINK MG MG B1201 O HOH B2051 1555 1555 2.16 LINK MG MG B1201 O HOH B2052 1555 1555 2.00 LINK O HOH C2043 MG MG D1201 1555 1555 2.11 LINK O HOH C2045 MG MG D1201 1555 1555 2.21 LINK O HOH C2049 MG MG D1201 1555 1555 2.23 LINK MG MG D1201 O HOH D2029 1555 1555 2.26 LINK MG MG D1201 O HOH D2030 1555 1555 2.06 LINK MG MG D1201 O HOH D2031 1555 1555 1.96 CISPEP 1 ILE A 51 PRO A 52 0 9.63 CISPEP 2 ILE B 51 PRO B 52 0 10.74 CISPEP 3 ILE C 51 PRO C 52 0 9.59 CISPEP 4 ILE D 51 PRO D 52 0 8.43 SITE 1 AC1 9 PHE C 9 MET C 11 GLY C 13 ARG C 14 SITE 2 AC1 9 ASP C 96 MET C 99 TRP C 104 TYR C 152 SITE 3 AC1 9 GSH C1201 SITE 1 AC2 13 PHE D 9 MET D 11 GLY D 13 ARG D 14 SITE 2 AC2 13 GLN D 36 ASP D 96 MET D 99 TRP D 104 SITE 3 AC2 13 TYR D 152 LEU D 199 GSH D1202 HOH D2006 SITE 4 AC2 13 HOH D2032 SITE 1 AC3 8 MET A 11 GLY A 13 ARG A 14 ASP A 96 SITE 2 AC3 8 MET A 99 TRP A 104 TYR A 152 GSH A1201 SITE 1 AC4 11 TYR B 8 MET B 11 GLY B 13 ARG B 14 SITE 2 AC4 11 GLN B 36 ASP B 96 MET B 99 TRP B 104 SITE 3 AC4 11 TYR B 152 GSH B1202 HOH B2012 SITE 1 AC5 6 HOH C2043 HOH C2045 HOH C2049 HOH D2029 SITE 2 AC5 6 HOH D2030 HOH D2031 SITE 1 AC6 6 HOH A2044 HOH A2045 HOH A2049 HOH B2048 SITE 2 AC6 6 HOH B2051 HOH B2052 SITE 1 AC7 10 ASP C 97 TYR D 8 ARG D 14 TRP D 39 SITE 2 AC7 10 LYS D 50 ILE D 51 GLN D 63 SER D 64 SITE 3 AC7 10 CWC D1200 HOH D2022 SITE 1 AC8 14 TYR C 8 ARG C 14 TRP C 39 LYS C 43 SITE 2 AC8 14 LYS C 50 ILE C 51 PRO C 52 GLN C 63 SITE 3 AC8 14 SER C 64 CWC C1200 HOH C2009 HOH C2027 SITE 4 AC8 14 HOH C2048 ASP D 97 SITE 1 AC9 14 ASP A 97 TYR B 8 ARG B 14 TRP B 39 SITE 2 AC9 14 LYS B 43 LYS B 50 ILE B 51 PRO B 52 SITE 3 AC9 14 GLN B 63 SER B 64 CWC B1200 HOH B2015 SITE 4 AC9 14 HOH B2016 HOH B2034 SITE 1 BC1 13 TYR A 8 ARG A 14 TRP A 39 LYS A 43 SITE 2 BC1 13 LYS A 50 ILE A 51 GLN A 63 SER A 64 SITE 3 BC1 13 CWC A1200 HOH A2008 HOH A2024 HOH A2050 SITE 4 BC1 13 ASP B 97 CRYST1 124.802 124.802 106.884 90.00 90.00 90.00 I 41 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008013 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008013 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009356 0.00000